P04439 (HLAA_HUMAN) Homo sapiens (Human)

HLA class I histocompatibility antigen, A alpha chain UniProtKBInterProSTRINGInteractive Modelling

365 aa; Sequence (Fasta) ; (Isoform 2); 1 identical sequence: Homo sapiens: B1PKY1

Available Structures

359 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of HLA-A3*01 in complex with a mutant beta-catenin peptide Heteromer
P35222; P61769;
25-302
MES; 10×SO4;PEG;
Assess
Crystal Structure of HLA-A*03:01 in complex with VVRPSVASK, an 9-mer epitope from Influenza B virus Heteromer
P13884; P61769;
25-301
SO4;
Assess
Crystal structure of HLA-A3*01 in complex with a wild-type beta-catenin peptide Heteromer
P35222; P61769;
25-301
PG4;MES;IMD;PEG;EDO;
Assess
HLA-A02 carrying YLGGPDFPTI Heteromer
P61769;
25-299
14×EDO;SO4;
Assess
HLA-A02 carrying MVWGPDPLYV Heteromer
P61769;
25-299
10×EDO;GOL;
Assess
A structural basis for immunodominant human T-cell receptor recognition. Heteromer
P01848; P01850; P61769;
25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide A7H v… Heteromer
P61769; Q6SW59;
25-299
Assess
CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX Heteromer
P43358; P61769;
25-299
1PG;
Assess
Crystal structure of HLA-A*1101 with sars nucleocapsid peptide Heteromer
P59595; P61769;
25-299
SO4;GOL;
Assess
HLA-A02 carrying RQWGPDPAAV Heteromer
P61769;
25-299
18×EDO;GOL;MES;SO4;ACY;
Assess
HLA-A02 carrying YLGGPDFPTI Heteromer
P61769;
25-299
BR; 17×EDO;GOL; 11×PG4;
Assess
Engineered Human HLA_A2 MHC Class I molecule in complex with NV9 peptide Heteromer
P61769;
24-298
GOL;CO;
Assess
HAL-A02 carrying RQFGPDFPTI Heteromer
P61769;
25-299
10×EDO;GOL;SO4;CA;
Assess
HLA Class I antigen Heteromer
P40967; P61769;
25-299
18×EDO; 10×GOL;SO4;
Assess
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L su… Heteromer
P61769; Q16655;
25-299
GOL;FMT;NA;
Assess
HLA A02 presenting SLYNTIATL Heteromer
P04591; P61769;
25-299
EDO;GOL;
Assess
T cell cross-reactivity and conformational changes during TCR engagement. Heteromer
P61769;
25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P03485; P61769;
25-299
Assess
Human Class I MHC HLA-A2 in complex with the HuD (G2L) peptide variant Heteromer
P61769;
25-299
GOL;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Human Prostaglandin Transporter dec… Heteromer
P61769; Q92959;
25-299
Assess
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT Heteromer
P61769;
25-299
Assess
Crystal Structure of HLA-A68 presenting a C-terminally extended peptide Heteromer
P30279; P61769;
25-299
EDO;NI;CD;CO;
Assess
HLA-A2.1 KVAEIVHFL Heteromer
E0YFW1; P61769;
25-299
Assess
HLA-A02 carrying RQFGPDWIVA Heteromer
P61769;
25-299
11×EDO;SO4;CA;GOL;
Assess
Ca2+ release from the endoplasmic reticulum of NY-ESO-1 specific T cells is modulated by the affini… Heteromer
P61769; P78358;
25-299
Assess
Structure of HLA-A2 in complex with an altered peptide ligands based on Mart-1 variant epitope Heteromer
P61769; Q16655;
25-299
GOL;
Assess
Human Class I MHC HLA-A2 in complex with the HuD peptide Heteromer
P61769;
25-299
GOL;
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P35222; P61769;
25-299
CD;MG;GOL;
Assess
HLA A02 presenting SLFNTIAVL Heteromer
P04591; P61769;
25-299
EDO;GOL;SO4;
Assess
Human HLA-A*0201-ALWGPDPAAA Heteromer
P01308; P61769;
25-299
Assess
Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide Heteromer
P61769; Q16655;
25-299
GOL;NA;
Assess
HLA-A02 carrying AQWGPDPAAA Heteromer
P01308; P61769;
25-299
Assess
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L su… Heteromer
P61769; Q16655;
25-299
GOL;NA;
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01848; P01850; P61769; P78358;
25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P61769; Q9Y4H2;
25-299
CD;MG;GOL;
Assess
Human Class I MHC HLA-A2 in complex with the HuD (G2L,I9V) peptide variant Heteromer
P61769;
25-299
GOL;
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P35222; P61769;
25-299
GOL;MG;CD;
Assess
Structure of HLA-A2 P130 Heteromer
P61769; Q76R61;
25-299
SO4;
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2 Heteromer
P61769;
25-299
GOL;
Assess
Human Class I MHC HLA-A2 in complex with the modified HTLV-1 TAX (Y5K-4-[3-Indolyl]-butyric acid) p… Heteromer
P61769;
25-299
GOL;NA;FMT;
Assess
TCR F50 recgonizing M1-HLA-A2 Heteromer
P03485; P61769;
25-299
Assess
Crystal Structure of RTY Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P61769; Q8WVV4;
25-299
NA;EDO;
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNPGMAV Heteromer
P03314; P61769;
25-299
EDO;EPE;PEG;SO4;
Assess
Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide Heteromer
P61769; Q16655;
25-299
GOL;NA;
Assess
Peptide length determines the outcome of T cell receptor/peptide-MHCI engagement Heteromer
P61769;
25-299
18×EDO;GOL;SO4;
Assess
Human Leukocyte Antigen presenting ILGKFLHRL Heteromer
O14746; P61769;
25-299
15×EDO;GOL;SO4;
Assess
Crystal Structure of ILNAMIVKI peptide bound to HLA-A2 Heteromer
P61769;
25-299
ACT;GOL;MG;
Assess
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV… Heteromer
P61769;
25-299
Assess
Crystal Structure of a citrulline peptide variant of the minor histocompatibility peptide HA-1 in c… Heteromer
P61769;
25-299
Assess
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V Heteromer
P61769;
25-299
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1 Heteromer
P61769;
25-299
GOL;
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P30305; P61769;
25-299
CD;MG;GOL;
Assess
Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2 Heteromer
P40967; P61769;
25-299
GOL;
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P30305; P61769;
25-299
GOL;CD;MG;
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5T peptide variant Heteromer
P61769;
25-299
Assess
Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2 Heteromer
P40967; P61769;
25-299
13×GOL;
Assess
Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1… Heteromer
P61769;
25-299
ZN;
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2.1 Heteromer
P61769;
25-299
GOL;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide V5M v… Heteromer
P61769; Q03463;
25-299
Assess
Human Leukocyte Antigen A02 presenting ILAKFLHEL Heteromer
O14746; P61769;
25-299
10×EDO;CA;MES;SO4;GOL;
Assess
Human Class I MHC HLA-A2 in complex with the Tel1p peptide Heteromer
P38110; P61769;
25-299
GOL;
Assess
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) (R1Y) peptide variant. Heteromer
P19544; P61769;
25-299
GOL;
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Bin… Heteromer
P01848; P61769; P78358;
25-299
GOL;MG;SO4;IPA;EPE;
Assess
Crystal Structure of the minor histocompatibility peptide HA-1Arg in complex with HLA-A2 Heteromer
P61769;
25-299
Assess
Crystal structure of an lmp2a-derived peptide bound to human class i mhc hla-a2 Heteromer
P13285; P61769;
25-299
IOD;EDO;CL;
Assess
A2 HLA complex with L8A heteroclitic variant of Melanoma peptide Heteromer
P61769;
25-299
11×GOL;MES;
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01848; P01850; P61769; P78358;
25-299
Assess
Rational development of high-affinity T-cell receptor-like antibodies Heteromer
P61769; P78358;
25-299
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5Q peptide variant Heteromer
P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P61769;
25-299
MES;
Assess
Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide Heteromer
P61769; Q16655;
25-299
GOL;
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1.1 Heteromer
P61769;
25-299
GOL;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1406-1415 decapeptide Heteromer
P61769; Q9DIT6;
25-299
Assess
Crystal Structure of ILNAMITKI peptide bound to HLA-A2 Heteromer
P61769; Q68CZ6;
25-299
GOL;NA;
Assess
A2 HLA complex with G4A heteroclitic variant of Melanoma peptide Heteromer
P61769;
25-299
GOL;EDO;SO4;
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P61769; Q9Y4H2;
25-299
CD;CO;
Assess
Crystal structure of a complex between the human adenovirus type 2 E3-19K protein and MHC class I m… Heteromer
P0C213; P61769; P68979;
25-299
Assess
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the E63Q and K66A mu… Heteromer
P14079; P61769;
25-299
13×GOL;SCN;
Assess
Crystal Structure of the minor histocompatibility peptide HA-1His in complex with HLA-A2 Heteromer
P61769; Q92619;
25-299
Assess
HLA Class I antigen Heteromer
P40967; P61769;
25-299
EDO;GOL;
Assess
1E6 TCR in complex with HLA-A02 carrying RQFGPDWIVA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
25-299
15×EDO;PG4;SO4;GOL;
Assess
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) peptide Heteromer
P19544; P61769;
25-299
GOL;
Assess
Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1 Heteromer
P01849; P04213; P61769; Q9NPA0;
25-299
Assess
THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE Heteromer
P27797; P61769;
25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P61769;
25-299
GOL;MES;
Assess
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance Heteromer
P61769; Q9YYH6;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
25-299
Assess
Crystal Structure of HLA-A*0201 in complex with NA231, an influenza epitope Heteromer
P61769; Q9Q0U7;
25-299
Assess
Structure of HLA-A2 P130 Heteromer
P61769;
25-299
PEG;
Assess
HLA-A2.1 KVAELVHFL Heteromer
E0YFW1; P61769;
25-299
Assess
Human Class I MHC HLA-A2(A150P) in complex with the Tel1p peptide Heteromer
P38110; P61769;
25-299
GOL;
Assess
HLA Class I antigen Heteromer
A0A0B4J279; A0A592; A0A5B9; P01848; P40967; P61769;
25-299
10×EDO;GOL;SO4;
Assess
A T cell receptor in complex with HLA-A0201 restricted Hepatitis C virus NS3 peptide (KLVALGINAV) Heteromer
P27958; P61769;
25-299
Assess
1E6 TCR in complex with HLA-A02 carrying RQFGPDFPTI Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
25-299
30×EDO;GOL;SO4;
Assess
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the K66A mutation in… Heteromer
P14079; P61769;
25-299
14×GOL;
Assess
Crystal structure of LS01-TCR/M1-HLA-A*02 complex Heteromer
P03485; P61769;
25-299
GOL;
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476 Heteromer
P03366; P61769;
25-299
MES;GOL;
Assess
Human Class I MHC HLA-A2(A150P) in complex with the Tax peptide Heteromer
P61769;
25-299
GOL;
Assess
Directed Evolution of Human T-cell Receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01848; P61769; P78358;
25-299
NA;GOL;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P61769; Q16655;
25-299
Assess
Crystal structure of HLA-A0201 in complex with an azobenzene- containing peptide Heteromer
P61769;
25-299
IPA;
Assess
Crystal structure of non-phosphorylated form of AMPD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q01433;
25-299
EDO;NA;
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNGPMQV Heteromer
P03314; P61769;
25-299
EDO;GOL;PEG;
Assess
A2 HLA complex with E1A heteroclitic variant of Melanoma peptide Heteromer
P61769;
25-299
GOL;SO4;
Assess
1E6 TCR in complex with HLA-A02 carrying YQFGPDFPIA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
25-299
SO4;EDO;
Assess
HLA Class I antigen Heteromer
P40967; P61769;
25-299
GOL;EDO;SO4;
Assess
CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX Heteromer
P61769;
25-299
Assess
Crystal Structure of ILNAMIAKI peptide bound to HLA-A2 Heteromer
P61769; Q68CZ6;
25-299
GOL;
Assess
Crystal structure of HLA-A2*0201 in complex with a nonameric altered peptide ligand (ALGIGILTV) fro… Heteromer
P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
25-299
Assess
Crystal structure of a H5-specific CTL epitope variant derived from H5N1 influenza virus in complex… Heteromer
P61769; Q1WDM0;
25-299
Assess
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOM… Heteromer
P43357; P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
O11822; P61769;
25-299
Assess
Crystal Structure of the human cytomegalovirus protein US2 bound to the MHC class I molecule HLA-A2… Heteromer
P09713; P14079; P61769;
25-299
Assess
CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VA… Heteromer
P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
25-299
Assess
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 Heteromer
P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
O11818; P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
25-299
Assess
Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal bin… Heteromer
P01848; P61769; P78358;
25-299
SO4; 11×GOL;CA;MG;EPE;
Assess
Newly identified epitope Mn2 from SARS-CoV M protein complexed withHLA-A*0201 Heteromer
P59596; P61769;
25-299
Assess
STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY … Heteromer
P04602; P61769;
25-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNGPIAV Heteromer
P03314; P61769;
25-299
GOL;EDO;SO4;PEG;
Assess
Crystal Structure Determination Of HLA A2 Complexed to Peptide GP2 with the substitution (I2L/V5L/L… Heteromer
P61769;
25-299
Assess
Human Leukocyte Antigen A02 presenting ILAKFLHTL Heteromer
O14746; P61769;
25-299
SO4;EDO;
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified TAX (Y5F) peptide Heteromer
P61769;
25-299
11×GOL;
Assess
Crystal structure of a H5-specific CTL epitope derived from H5N1 influenza virus in complex with HL… Heteromer
P61769; Q2F4V2;
25-299
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… Heteromer
P01848; P61769; P78358;
25-299
SO4;PGE;7PE; 11×GOL;
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 envelope peptide env120-128 Heteromer
P04583; P61769;
25-299
MES;GOL;
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P03485; P61769;
25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a Peiodate- cleavable peptide Heteromer
P06725; P61769;
25-299
GOL;MES;
Assess
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P61769;
25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to Cytomegalovirus (CMV) pp65 epitope Heteromer
P06725; P61769;
25-299
GOL;
Assess
Crystal structure of non-phosphorylated form of RTF PHOSPHOPEPTIDE BOUND TO HLA-A2 in complex with … Heteromer
O15061; P61769; Q8NHL6;
25-299
Assess
Crystal Structure Determination of HLA-A2.1 Complexed to GP2 Peptide Variant(I2L/V5L) Heteromer
P61769;
25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P61769;
25-299
GOL;MES;
Assess
NYBR1-A2-SLSKILDTV Heteromer
A0A0B4J277; A0A584; K7N5M3; K7N5M4; P61769; Q9BXX3;
25-299
PEG;EDO;GOL;SO4;EPE;
Assess
HLA2.1 KVAELVWFL Heteromer
E0YFW1; P61769;
25-299
Assess
1E6 TCR in Complex with HLA-A0e carrying RQWGPDPAAV Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
25-299
12×EDO;GOL;SO4;
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to residual fragments of a photocleavable peptide t… Heteromer
P61769;
25-299
GOL;
Assess
A2-MHC Complex carrying FLTGIGIITV Heteromer
P61769;
25-299
EDO;SO4;GOL;
Assess
The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
K7N5M3; K7N5M4; P61769; Q16655;
25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P61769; Q16655;
25-299
Assess
Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant H… Heteromer
O11822; P61769;
25-299
Assess
Crystal structure of HLA-A2 in complex with LILRB1 Heteromer
P04585; P61769; Q8NHL6;
25-299
Assess
Crystal structure of DMF5 TCR bound to HLA-A2 presenting synthetic peptide SMLGIGIVPV Heteromer
P61769;
25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P61769;
25-299
Assess
Large CDR3a loop alteration as a function of MHC mutation Heteromer
P04213; P61769; Q9NPA0;
25-299
Assess
Structures of HLA-A*1101 in complex with immunodominant nonamer and decamer HIV-1 epitopes clearly … Heteromer
P12499; P61769;
25-299
Assess
POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTE… Heteromer
P04626; P61769;
25-299
Assess
Crystal structure of HLA-A1101 in complex with an azobenzene- containing peptide Heteromer
P61769;
25-299
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P61769; Q16655;
25-299
EPE;SO4;
Assess
MHC A02 Allele presenting MTSAIGILVP Heteromer
P61769;
25-299
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P61769;
25-299
TAM; 11×SO4;
Assess
Crystal structure of LS10-TCR/M1-HLA-A*02 complex Heteromer
P03485; P61769;
25-299
EDT;
Assess
1E6 TCR in complex with HLA-A02 carrying MVW peptide Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
25-299
EDO;SO4;GOL;
Assess
HLA class I histocompatibility antigen Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
25-299
SO4;
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04588; P61769;
25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P14079; P61769;
25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P61769;
25-299
Assess
Crystal structure of the T-cell receptor NYE_S1 bound to HLA A2*01-SLLMWITQV Heteromer
P61769; P78358;
25-299
Assess
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 Heteromer
A0A0K0K1A5; A0A5B9; P01848; P04437; P14079; P61769;
25-299
Assess
AH3 recognition of mutant HLA-A2 W167A Heteromer
P01849; P61769; Q9NPA0;
25-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWAGPMAV Heteromer
P03314; P61769;
25-299
NA;EDO;SO4;GOL;
Assess
CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX Heteromer
P61769; Q9NPA0;
25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P03485; P61769;
25-299
Assess
RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2 Heteromer
A0A075B6T6; A0A0K0K1A5; P61769; Q16655;
25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a peptide representing the epitope of the H5N1 (… Heteromer
P61769; Q33CG5;
25-299
GOL;MES;
Assess
The complex between high affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
P61769; Q16655;
25-299
Assess
Crystal structure of the T-cell receptor NYE_S2 bound to HLA A2*01-SLLMWITQV Heteromer
P61769; P78358;
25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5K-4-[3-Indo… Heteromer
P01848; P01850; P61769;
25-299
SO4; 13×GOL;3IB;
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P61769; Q16655;
25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04582; P61769;
25-299
Assess
1E6-A*0201-ALWGPDPAAA Complex, Triclinic Heteromer
P01308; P61769;
25-299
Assess
Structure of HLA-A2 in complex with D76N b2m mutant and NY-ESO1 double mutant Heteromer
P61769;
25-299
CL;GOL;
Assess
COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 Heteromer
P01732; P61769;
25-299
Assess
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) peptide Heteromer
P01848; P61769;
25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound HuD peptide Heteromer
P01848; P61769;
25-299
GOL;SO4;
Assess
an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV Heteromer
P27958; P61769;
25-299
Assess
Crystal structure of non-phosphorylated form of RQA_V phosphopeptide bound to HLA-A2 in complex wit… Heteromer
P33241; P61769; Q8NHL6;
25-299
EDO;
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P61769;
25-299
SO4;GOL;
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNGPMHV Heteromer
P03314; P61769;
25-299
PEG;SO4;GOL;
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound Tel1p peptide Heteromer
P38110; P61769;
25-299
GOL;
Assess
Human Leukocyte Antigen A02 presenting ILGKFLHWL Heteromer
O14746; P61769;
25-299
EDO;SO4;
Assess
1E6-A*0201-ALWGPDPAAA Complex, Monoclinic Heteromer
P01308; P61769;
25-299
SO4;
Assess
The complex between the high affinity version of A6 TCR (A6c134) and human Class I MHC HLA-A2 with … Heteromer
P0C213; P61769;
25-299
10×GOL;
Assess
TCR-peptide specificity overrides affinity enhancing TCR-MHC interactions Heteromer
H2RG00; K7N5N2; O14746; P01850; P61769;
25-299
GOL;EDO;
Assess
868 TCR in complex with HLA A02 presenting SLYFNTIAVL Heteromer
P04591; P61769;
25-299
13×EDO;GOL;SO4;
Assess
Structure of 5F3 TCR in complex with HLA-A2/MART-1 Heteromer
P61769; Q6PJ56;
25-299
NAG;
Assess
A2-MHC Complex carrying FATGIGIITV Heteromer
P61769;
25-299
SO4;
Assess
Crystal structure of human class i mhc (hla-a2.1) complexed with beta 2-microglobulin and hiv-rt va… Heteromer
P61769;
25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(3,4-difluo… Heteromer
P01850; P61769;
25-299
GOL;
Assess
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V Heteromer
P61769;
25-299
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… Heteromer
P01848; P61769; Q16655;
25-299
Assess
Newly identified epitope from SARS-CoV membrane protein complexed with HLA-A*0201 Heteromer
P59596; P61769;
25-299
Assess
Crystal Structure of HLA-A*2402 Complexed with a telomerase peptide Heteromer
O14746; P61769;
25-299
SO4;GOL;
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(4-fluoroPh… Heteromer
P01848; P01850; P61769;
25-299
GOL;
Assess
HLA class I histocompatibility antigen Heteromer
P61769;
25-299
EPE;SO4;EDO;
Assess
Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor Heteromer
A0A0B4J277; A0A0K0K1A5; K7N5M3; K7N5M4; O14746; P61769;
25-299
EDO;GOL;SO4;
Assess
Large CDR3a loop alteration as a function of MHC mutation. Heteromer
P01849; P04213; P61769; Q9NPA0;
25-299
Assess
868 TCR in complex with HLA A02 presenting SLYNTIATL Heteromer
P04591; P61769;
25-299
EDO;GOL;SO4;
Assess
Rational development of high-affinity T-cell receptor-like antibodies Heteromer
P61769; P78358;
25-299
Assess
CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUT… Heteromer
P61769;
25-299
Assess
MHC A02 Allele presenting MTSAIGILPV Heteromer
P61769;
25-299
Assess
868 TCR in complex with HLA A02 presenting SLYNTVATL Heteromer
P04591; P61769;
25-299
EDO;SO4;
Assess
The complex between TCR a7b2 and human Class I MHC HLA-A0201-WT1 with the bound RMFPNAPYL peptide. Heteromer
P19544; P61769;
25-299
EDO;
Assess
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-G4E Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P01848; P61769;
25-299
Assess
The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… Heteromer
A0A075B6T6; A0A1B0GXE1; K7N5M4; P01848; P61769; Q16655;
25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P12901; P61769;
25-299
Assess
Structural basis for ineffective T-cell responses to MHC anchor residue improved heteroclitic pepti… Heteromer
P61769; Q16655;
25-299
EDO;
Assess
Structure of ESK1 in complex with HLA-A*0201/WT1 Heteromer
P19544; P61769;
25-299
Assess
1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01308; P01848; P61769;
25-299
Assess
Structure of wtMHC class I with NY-ESO1 double mutant Heteromer
P61769;
25-299
CL;GOL;
Assess
Crystal structure of the T-cell receptor NYE_S3 bound to HLA A2*01-SLLMWITQV Heteromer
P61769; P78358;
25-299
Assess
HLA class I histocompatibility antigen Heteromer
P61769;
25-299
SO4;
Assess
Crystal structure of non-phosphorylated form of RLS PHOSPHOPEPTIDE BOUND TO HLA-A2 in complex with … Heteromer
P61769; Q8NC44; Q8NHL6;
25-299
Assess
human 199.54-16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6T6; A0A0C4ZKA8; A0A5B3; K7N5N2; P61769; Q16655;
25-299
SCN;K;CL;
Assess
human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6N1; P01848; P61769; Q16655;
25-299
NA;
Assess
HLA-A2 (A*02:01) bound to a peptide from the Epstein-Barr virus BRLF1 protein Heteromer
P61769; Q3KSS7;
25-299
Assess
Neoantigen p53R175H-specific TCR 6-11 binds to p53R175H-HLA-A2 Heteromer
P04637; P61769;
25-299
Assess
Crystal Structure of HLA-A2 Bound to LIR-1, a Host and Viral MHC Receptor Heteromer
P12499; P61769; Q8NHL6;
25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide Heteromer
P61769; Q3KSU1;
25-298
Assess
Crystal structure of HA-1 minor histocompatibility antigen bound to human class I MHC HLA-A2 Heteromer
P61769; Q92619;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide Heteromer
P61769; Q03463;
25-298
CIT;
Assess
Crystal structure of BRLF peptide from EBV in complex with HLA-A1101. Heteromer
P61769;
25-298
GOL;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with AFP137 nonapeptide Heteromer
P02771; P61769;
25-298
Assess
The structure of HLA-A*3003/NP44 Heteromer
P61769; Q9Q0U8;
25-298
Assess
Crystal Structure of HLA-A*0201 in complex with FLNDK, a 15 mer self-peptide Heteromer
P61769;
25-298
PEG;CL;
Assess
Structure of HLA-A2:01 with the 12-mer peptide F12K Heteromer
B6KDY1; P61769;
25-298
GOL;
Assess
The structure of HLA-A*3001/RT313 Heteromer
P04585; P61769;
25-298
Assess
The structure of HLA-A*3003/MTB Heteromer
P61769; P9WNK3;
25-298
Assess
HLA-A*1101 in complex with HBV peptide homologue Heteromer
P61769;
25-298
SO4;
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV peptide Heteromer
P06725; P61769;
25-298
Assess
Crystal Structure of PKD2 Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P61769; Q9BZL6;
25-298
EDO;
Assess
Crystal Structure of RQA_M Phosphopeptide Bound to HUMAN Class I MHC HLA-A2 Heteromer
P33241; P61769;
25-298
EDO;
Assess
Crystal structure of peptide in complex with HLA-A1101. Heteromer
P61769;
25-298
GOL;
Assess
HLA-A24 in complex with HIV-1 Nef126-10(8I10F) Heteromer
P04603; P61769;
25-298
Assess
Crystal Structure of HLA-A*0201 in complex with ALQDA, a 15 mer self-peptide Heteromer
P61769;
25-298
CL;PEG;MG;
Assess
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PB1 (498-5… Heteromer
P61769; Q9YXL6;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6G v… Heteromer
P06725; P61769;
25-298
Assess
Crystal structure of AMPD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q01433;
25-298
EDO;
Assess
The High Resolution Crystal Structure of HLA-A1 Complexed with the MAGE-A1 Peptide Heteromer
P43355; P61769;
25-298
GOL;
Assess
The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(6L) peptide Heteromer
P61769; Q9WPU2;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6C v… Heteromer
P06725; P61769;
25-298
Assess
Crystal structure of 10-mer peptide from EBV in complex with HLA-A1101. Heteromer
P13285; P61769;
25-298
GOL;
Assess
Structure of HLA-A68 complexed with a tumor antigen derived peptide Heteromer
P40126; P61769;
25-298
GOL;
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8A peptide variant Heteromer
P61769;
25-298
Assess
Structure of HLA-A2:01 with peptide G9L Heteromer
P61769;
25-298
GOL;
Assess
Structure of HLA-A2:01 with the 11-mer peptide F11V Heteromer
P61769; S7UWA0;
25-298
GOL;
Assess
Crystal Structure of HLA-A*68:01 in complex with NP145-156, a 12 mer influenza peptide Heteromer
P61769; Q9Q0U8;
25-298
IOD;MG;SO4;
Assess
Crystal structure of non-phosphorylated form of PKD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q9BZL6;
25-298
CD;GOL;
Assess
Crystal Structure of HLA-A*0201 in complex with M1-G4E Heteromer
P61769;
25-298
Assess
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009H1N1 PB1 (496-50… Heteromer
P61769; Q9YXL6;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide M5A v… Heteromer
P61769; Q6SW59;
25-298
Assess
Crystal structure of dual peptide from EBV in complex with HLA-A*11:01 Heteromer
P13285; P61769;
25-298
GOL;
Assess
HLA-A24 in complex with HIV-1 Nef134-10(wt) Heteromer
P61769; Q9YYU8;
25-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5V peptide variant Heteromer
P61769;
25-298
Assess
Crystal structure of HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P42336; P61769;
25-298
GOL;FMT;
Assess
HIV RT derived peptide complexed to HLA-A*0301 Heteromer
P61769; Q9YV12;
25-298
Assess
Crystal structure of RQA_V phosphopeptide bound to HLA-A2 Heteromer
P33241; P61769;
25-298
EDO;NA;
Assess
Crystal Structure of HLA A*0101 in complex with NP44-S7N, an 9-mer influenza epitope Heteromer
P61769; Q07FI1;
25-298
Assess
Newly identified epitope V60 from HBV core protein complexed with HLA-A*0201 Heteromer
P61769; Q9QAC5;
26-299
Assess
HLA-A24 in complex with HIV-1 Nef126-10(8T10F) Heteromer
P61769; Q77378;
25-298
Assess
Crystal Structure of HLA-A*0201 in complex with M1-F5L Heteromer
P61769;
25-298
Assess
Crystal structure of HLA-A*03:01 in complex with a wild-type PIK3CA peptide Heteromer
P42336; P61769;
25-298
GOL;
Assess
HLA*A2402 complexed with HIV nef138 Y2F mutant 10mer epitope Heteromer
P04601; P61769;
25-298
Assess
Crystal Structure of HLA-A*0201 in complex with M1-L3W Heteromer
P61769;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide G4M-V… Heteromer
P61769; Q03463;
25-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8V peptide variant Heteromer
P61769;
25-298
Assess
PF6-M1-HLA-A2 Heteromer
P03485; P61769;
25-298
Assess
Crystal structure of PKD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q9BZL6;
25-298
CD;GOL;
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5S peptide variant Heteromer
P61769;
25-298
Assess
Crystal structure of human 0606T1-2 TCR bound to HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P42336; P61769;
25-298
13×GOL;
Assess
Crystal structure of HLA-A1:MAGE-A1 in complex with Fab-Hyb3 Heteromer
P43355; P61769;
25-298
GOL;
Assess
HLA*A2402 complex with HIV nef138 Y2F-8mer mutant epitope Heteromer
P04601; P61769;
25-298
Assess
Crystal Structure Analysis of NY-ESO-1 epitope, SLLMWITQC, in complex with HLA-A2 Heteromer
P61769; P78358;
25-298
SO4;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P61769; Q16655;
25-298
Assess
Crystal Structure of KMD Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P61769; Q86UW6;
25-298
EDO;
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
25-298
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-8(2F) Heteromer
P04601; P61769;
25-298
Assess
Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQS, in complex with HLA-A2 Heteromer
P61769;
25-298
SO4;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide T4P v… Heteromer
P61769; Q3KSU1;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS4b-1807-1816 decapeptide Heteromer
P61769; Q9DIT6;
25-298
Assess
Crystal structure of LMP2 peptide from EBV in complex with HLA-A*11:01 Heteromer
P13285; P61769;
25-298
GOL;
Assess
HIV Nef derived peptide Nef73 complexed to HLA-A*0301 Heteromer
P04601; P61769;
25-298
Assess
Crystal Structure of HLA A*0101 in complex with NP44, an 9-mer influenza epitope Heteromer
P03466; P61769;
25-298
Assess
HLA*A2402 complexed with HIV nef138 10mer epitope Heteromer
P04601; P61769;
25-298
Assess
Recognition of peptide-MHC by a V-delta/V-beta TCR Heteromer
P61769; Q9YYU8;
25-298
Assess
Structure of HLA-A68 complexed with an HIV derived peptide Heteromer
P61769; Q9YXY3;
25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-8(wt) Heteromer
P04601; P61769;
25-298
Assess
MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P01848; P61769; Q8WZ42;
25-298
GOL; 11×SO4;
Assess
HLA*A2402 complexed with HIV nef138 8mer epitope Heteromer
P04601; P61769;
25-298
Assess
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PA (649-65… Heteromer
P61769; Q9YXL3;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide N3S v… Heteromer
P61769; Q03463;
25-298
Assess
The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(wt) peptide Heteromer
P61769; Q9YYU8;
25-298
Assess
Newly identified epitope N1 derived from SARS-CoV N protein complexed with HLA-A*2402 Heteromer
P59595; P61769;
25-298
Assess
Crystal Structure of HLA-A*1101 in complex with H1-22, an influenza A(H1N1) virus epitope Heteromer
P61769; P68043;
25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide C6V v… Heteromer
P61769; Q03463;
25-298
Assess
Human Class I MHC HLA-A2 in complex with synthetic peptide MMWDRGLGMM Heteromer
P61769;
25-298
Assess
The complex between C1-28 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide Heteromer
P61769; Q9YYU3;
25-298
CO;
Assess
Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQA, in complex with HLA-A2 Heteromer
P61769;
25-298
SO4;
Assess
Crystal structure of killer cell immunoglobulin-like receptor KIR2DS2 in complex with HLA-A Heteromer
P43631; P61769; Q76ZQ3;
25-298
Assess
Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide Heteromer
A0A0B4J279; A0A0K0K1A5; K7N5M4; K7N5N2; P61769;
25-298
GOL;ACT;
Assess
HLA-A24 in complex with HIV-1 Nef134-10(6L) Heteromer
P61769; Q9WPU2;
25-298
Assess
Structure of HLA-A2:01 with peptide Y9L Heteromer
P61769;
25-298
GOL;
Assess
Crystal Structure of HLA-A*1101 in complex with H7-22, an influenza A(H7N9) virus epitope Heteromer
P61769; Q9Q0U8;
25-298
Assess
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 Heteromer
A0A075B6T6; A0A0K0K1A5; A0A5B9; P01848; P14079; P61769;
25-298
EMC;
Assess
Crystal structure of a MHC class I-peptide complex Heteromer
P60201; P61769;
25-298
Assess
The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide in space group P2121… Heteromer
P61769; Q9YYU3;
25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-10(2F) Heteromer
P61769; Q9YYU3;
25-298
Assess
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P01848; P43357; P61769;
25-298
SO4;
Assess
Crystal structure of peptide-HLA-A24 bound to S19-2 V-delta/V-beta TCR Heteromer
P03407; P61769;
25-298
Assess
Structure of HLA-A2:01 with peptide Y10L Heteromer
P61769;
25-298
GOL;
Assess
The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide Heteromer
P61769; Q9YYU3;
25-298
Assess
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01848; P01850; P61769; P78358;
25-298
Assess
Crystal Structure of HLA-A*2402 in complex with 2009 pandemic influenza A(H1N1) virus and avian inf… Heteromer
A0A0X9JHC1; P61769;
25-298
Assess
Plasticity of human CD8 binding to peptide-HLA-A*2402 Heteromer
P01732; P61769; Q9YYU8;
25-298
Assess
Structure of HLA-A68 complexed with an HIV Env derived peptide Heteromer
P61769; Q70626;
25-298
Assess
STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R Heteromer
P61769;
25-298
Assess
STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A Heteromer
P01848; P61769;
25-298
Assess
CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A Heteromer
P01848; P61769;
25-298
Assess
Crystal structure of the public RA14 TCR in complex with the HCMV dominant NLV/HLA-A2 epitope Heteromer
P01848; P61769;
25-298
SO4;CL;
Assess
Crystal Structure of HLA-A*11:01-GTS3 Heteromer
P61769; Q6YMS4;
25-298
K;
Assess
The complex between TCR JKF6 and human Class I MHC HLA-A2 presenting the MART-1(27-35)(A27L) peptide Heteromer
P61769; Q16655;
25-298
Assess
D30 TCR in complex with HLA-A*11:01-GTS1 Heteromer
A0A087WSZ9; K7N5N2; P17763; P61769;
25-298
Assess
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P61769; Q9UM73;
25-298
Assess
Crystal structure of human 21LT2-2 TCR bound to HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P42336; P61769;
25-298
ACT;GOL;
Assess
Crystal Structure of HLA-A*11:01 with GTS1 peptide Heteromer
P17763; P61769;
25-298
CL;
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
25-298
Assess
D30 TCR in complex with HLA-A*11:01-GTS3 Heteromer
A0A087WSZ9; K7N5N2; P61769; Q6YMS4;
25-298
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
25-298
Assess
Crystal structure of TCR C7 in complex with HCMV NLV epitope presented by HLA-A2 Heteromer
P18139; P61769;
26-299
Assess
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2 Heteromer
K7N5M3; P03485; P61769;
25-298
Assess
HLA-A*01:01 complex with NRAS Q61K peptide by NMR Heteromer
P01111; P61769;
25-298
Assess
Structure of the human PLC editing module Heteromer
O15533; P27797; P30101; P61769;
25-298
NAG;MAN;
Assess
Structure of HLA-A2:01 with peptide G9V Heteromer
P61769;
26-298
GOL;
Assess
Crystal structure of C25-NLV-HLA-A2 complex Heteromer
P18139; P61769;
26-298
IMD;
Assess
Structure of HLA-A2:01 with peptide G13E Heteromer
P61769;
26-298
Assess
Crystal structure of DMF5 TCR bound to HLA-A2 presenting synthetic peptide MMWDRGLGMM Heteromer
P61769;
26-298
Assess
Structure of HLA-A2:01 with peptide G11N Heteromer
P61769;
26-298
GOL;
Assess
Structure of HLA-A2:01 with peptide Y16R Heteromer
P61769;
26-298
GOL;NA;
Assess
Crystal structure of 1406 TCR bound to HLA-A2 with HCV 1406-1415 antigen peptide Heteromer
P27958; P61769;
25-296
Assess
Crystal structure of a complex between the Human adenovirus type 4 E3-19K protein and MHC class mol… Heteromer
P14079; P61769; Q8BEL5;
25-295
Assess
DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE Heteromer
P61769;
25-294
ALA;ARG;
Assess
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 Heteromer
P61769;
25-294
Assess
SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68 Heteromer
P61769;
25-294
Assess
STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 Heteromer
P61769;
25-294
Assess
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-F5L Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P01848; P61769;
25-269
Assess
THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE … Heteromer
P61769;
25-199
Assess
HIV-1 Nef in complex with MHC-I cytoplasmic domain and Mu1 adaptin subunit of AP1 adaptor (second d… Heteromer
P35585; Q90VU7;
338-356
Assess
Structure of HLA-DR1 with a bound peptide with non-optimal alanine in the P1 pocket Heteromer
P01903; P01911;
128-141
Assess
HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED… Heteromer
P01903; P01911;
128-141
Assess
HIV-1 Nef in complex with MHC-I cytoplasmic domain and Mu1 adaptin subunit of AP1 adaptor (second d… Heteromer
P35585; Q90VU7;
343-354
Assess
Structure of the HLA-E-VMAPRTLVL/GF4 TCR complex Heteromer
P13747; P61769;
3-11
Assess
HLA-A*0201 single chain trimer with HPV.16 E7 peptide LLMGTLGIVmonomer26-298
Assess
HLA-A*0201 single chain trimer with murine H2K alpha 3 domain and HPV.16 E7 peptide YMLDLQPETmonomer26-291
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7rtd.1.Amonomer0.8525-298
93.70
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27rtd.1.Amonomer0.8525-298
92.88
Assess